Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS)

Journal of the National Cancer Institute

Volumn 98, Issue 2, 2006, Pages 92-100

  Kulasingam, Shalini L ^a,e   Kim, Jane J ^b   Lawrence, William F ^c,g   Mandelblatt, Jeanne S ^c   Myers, Evan R ^a   Schiffman, Mark ^d,f   Solomon, Diane ^d,f   Goldie, Sue J ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD CENTER FOR RISK ANALYSIS   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e DUKE UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CLINICAL TRIAL; COLPOSCOPY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOPATHOLOGY; DATA ANALYSIS; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH ECONOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL CARE; MEDICAL DECISION MAKING; NONBIOLOGICAL MODEL; NONHUMAN; PATIENT REFERRAL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 31544476536     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj009     Document Type: Article

References (19)

1. ASCUS LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
2. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998;91:973-6.
3. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003;127:946-9.
4. Solomon D, Schiffman M, Throne R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
5. Solomon D, Schiffman M, Throne R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: Response to a November 2001 commentary. Obstet Gynecol 2002;99:671-4.
6. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
7. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-90.
8. Maxwell GL, Carlson JW, Ochoa M, Krivak T, Rose GS, Myers ER. Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries. Obstet Gynecol 2002;100:740-8.
9. Schiffman M, Hildesheim A, Herrero R, Bratti C. Human papillomavirus testing as a screening tool for cervical cancer. JAMA 2000;283:2525-6.
10. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000;92:397-402.
11. Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996.
12. Centers for Medicare and Medicaid Services. 2004 Clinical diagnostic laboratory fee schedule. Public Use File (PUF). Vol. 2005. Available at: http://www.cms.hhs.gov/providers/pufdownload/#labfee.
13. Centers for Medicare and Medicaid Services. 2004 Medicare physician fee schedule. Vol. 2005. Available at: http://www.cms.hhs.gov/physicians/pfs.
14. U.S. Bureau of Labor Statistics. Consumer price indexes. Washington (DC): U.S. Department of Labor; 2003. Available at http://www.bls.gov/cpi.
15. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-62.
16. Franco EL. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;31:89-96.
17. Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100-6.
18. Cullen J, Schwartz MD, Lawrence WF, Selby JV, Mandelblatt JS. Short-term impact of cancer prevention and screening activities on quality of life. J Clin Oncol 2004;22:943-52.
19. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.